Keyphrases
Alemtuzumab
66%
Antilymphocyte Globulin
66%
BK Nephropathy
100%
Cidofovir
33%
Cumulative Rates
100%
Geometric Mean
33%
Graft Dysfunction
33%
Graft Function
33%
Immunosuppression Reduction
33%
Induction Therapy
33%
Kidney Allograft
33%
Kidney Transplant Recipients
100%
Maintenance Immunosuppression
33%
Plasma Viral Load
33%
Retrospective Review
33%
Serum Creatinine
33%
Simultaneous Pancreas-kidney
66%
Simultaneous Pancreas-kidney Transplant
33%
Simultaneous Pancreas-kidney Transplantation
100%
Single Center
33%
Working Diagnosis
33%
Nursing and Health Professions
Alemtuzumab
100%
Allograft
50%
Cidofovir
50%
Creatinine Blood Level
50%
Graft Dysfunction
50%
Immunosuppressive Treatment
100%
Kidney Allograft
50%
Kidney Disease
100%
Kidney Graft
50%
Kidney Pancreas Transplantation
100%
Lymphocyte Antibody
100%
Transplantation
50%
Virus Load
50%
Medicine and Dentistry
Alemtuzumab
100%
Allograft
50%
Cidofovir
50%
Creatinine
50%
Graft Dysfunction
50%
Immunosuppressive Treatment
100%
Kidney Allograft
50%
Kidney Graft
50%
Kidney Pancreas Transplantation
100%
Lymphocyte Antibody
100%
Nephropathy
100%
Transplantation
50%
Immunology and Microbiology
Alemtuzumab
50%
Allograft
50%
Anti-Lymphocyte Globulin
50%
Creatinine Blood Level
25%
Immunosuppression
50%
Kidney Transplantation
100%
Leporidae
50%
Pancreas
100%
Viral Load
25%